Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

Mise à jour : Il y a 4 ans
Référence : NCT00630331

Femme et Homme

Extrait

The present study will evaluate clinical efficacy, safety, tolerability and immunogenicity of both Novartis Vaccines' cell-derived influenza vaccine and egg-derived influenza vaccine in healthy adults 18 to 49 years of age.


Critère d'inclusion

  • Influenza

Liens